Latest News
All Times Eastern
- My husband says we’ll be ‘homeless’ if we keep renting. We’re 68 and 74 — do we buy a home instead?
- I don’t want to leave my financially irresponsible daughter my house. Is that unreasonable?
- AI has supercharged online scams: With the holidays coming, here’s what to look out for
- Opinion Another U.S.-China conflict is escalating. This one could be the most serious of all.
- Why so many people are suddenly turning to GoFundMe to help pay off student debt
- Opinion China and the U.S. are testing the limits of global trade
- Opinion How could a politician engage in large-scale deception and win? Easy. Just ask George Santos.
- 5 unforgettable towns for a winter getaway
- OPEC may be ‘panicking’ as U.N. COP28 climate talks focus on possible fossil fuel phase-out, observers say
- Opinion Here’s how to know if your mutual fund sees ESG investing clearly
to be replaced
Orthofix Medical Inc.
OFIXUS
$
0.00
0.00%
After Hours
$
11.76
After Hours Volume:
5.84K
| Close | Chg | Chg % |
|---|---|---|
| $11.76 | 0.39 | 3.43% |
Volume: 755.12K
65 Day Avg: 810.82K
11.21
Day Range
11.89
9.58
52 Week Range
23.19
Partner Center
Your Watchlists
Recently Viewed Tickers
Overview
OFIX Overview
Key Data
- Open $11.37
- Day Range 11.21 - 11.89
- 52 Week Range 9.58 - 23.19
- Market Cap $432.26M
- Shares Outstanding 36.76M
- Public Float 35.46M
- Beta 0.94
- Rev. per Employee $612.14K
- P/E Ratio N/A
- EPS -$3.90
- Yield N/A
- Dividend N/A
- Ex-Dividend Date N/A
- Short Interest 3.34M 11/15/23
- % of Float Shorted 9.41%
- Average Volume 810.82K
Performance
| 5 Day |
|
| 1 Month |
|
| 3 Month |
|
| YTD |
|
| 1 Year |
|
Analyst Ratings
Number of Ratings 5
Full Ratings
Recent News
Orthofix Medical upgraded to buy from hold at Stifel Nicolaus
Medical device maker Orthofix warns that Q3 revenue will rise only in low-single digits as COVID delays procedures
Orthofix Medical Inc. said Wednesday it expects third-quarter revenue growth to come in at a low single-digit increase over the year-earlier period, hurt by the high volume of elective procedures that have been deferred o...
Orthofix Medical started at hold with $39 stock price target at Stifel Nicolaus
Orthofix started at buy with $49 stock price target at SunTrust RH
SEC fines Orthofix International $14 million for accounting failures, foreign bribery
The Securities and Exchange Commission said on Wednesday it would fine Orthofix International , a Texas-based medical device company, $14 million to settle charges that it improperly booked revenue in certain instances and...
Orthofix shares slide 2% in morning trade
Orthofix to restate results due accounting errors
Orthofix International NV said Tuesday it would restate its financial statements going back to 2011 after finding a series of accounting errors. The medical-device company found improper accounting of uncollectable patient...
Orthofix delays second-quarter earnings
Orthofix International NV postponed the release of its second-quarter results, as the medical-device company said it needs more time to review matters related to its sales and income totals in prior periods.
NuVasive shares plunge as customers defect
NuVasive Inc. (NUVA) lost a third of its market value Thursday after the maker of spinal products reduced its third-quarter revenue guidance because of customers and sales representatives defecting to smaller, lower-priced...
Orthofix to pay $34 mln to settle DOJ probe
Orthofix International N.V. (OFIX) has agreed to pay $34.2 million to settle False Claims Act allegations related to the medical-device company's sale of bone growth stimulator devices, the Department of Justice said.
Orthofix to sell sports-medicine unit for $157.5M
Orthofix International N.V. (OFIX) agreed to sell its sports medicine business Breg Inc. to private-equity firm Water Street Healthcare Partners for $157.5 million in cash in an effort to focus on its spine and orthopedic ...
Biomet joint sales suffer from economic slowdown
(Updates throughout with details on results, analyst comments.) --Replacement joint sales remain soft, similar to prior fiscal quarter --Biomet CEO cites volume and pricing pressure on industry, and says company isn't grow...
Brown-Forman, Acadia, ADC, InterMune, more
SAN FRANCISCO (MarketWatch) -- Among the companies whose shares are expected to see active trading in Tuesday's session are Brown-Forman Corp., Chico's FAS Inc., and ADC Telecommunications.
NRG Energy, NTL, Telewest, TiVo
A look at companies whose shares are expected to se active trade in Monday's session.
Orthofix (OFIX) Gets a Hold from BTIG
on TipRanks.com
Orthofix Medical: Q3 Earnings Insights
on Benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023
on Benzinga.com
Director James Hinrichs Acquires 7,500 Shares of Orthofix Medical Inc
Director James Hinrichs Acquires 7,500 Shares of Orthofix Medical Inc
on GuruFocus.com
Orthofix Medical Director Trades $101K In Company Stock
on Benzinga.com
Why Shares of Orthofix Medical Are Plummeting on Tuesday
on Motley Fool
JMP Securities Sticks to Their Hold Rating for Orthofix (OFIX)
on TipRanks.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
on Benzinga.com
Orthofix Medical Inc.
Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.